Nomura Holdings »

Halozyme Therapeutics shares owned by Nomura Holdings

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Nomura Holdings from 13F filings

Historical chart of Nomura Holdings investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Nomura Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Nomura Holdings

Quarter filed Position value Share count Share price at filing
2012-06-30 $0 1.6k 0.00

More positions owned by Nomura Holdings

Meta Platforms Cl A (META)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Dollar Tree (DLTR)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Select Sector Spdr Tr Energy Call Option (XLE)
Microsoft Corporation (MSFT)
Ishares Tr Msci Emg Mkt Etf Call Option (EEM)
Macy's (M)
Catalent (CTLT)
Western Digital (WDC)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Apple (AAPL)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Nomura Holdings

Top funds holding Halozyme Therapeutics

Vanguard Group
Artisan Partners Limited Partnership
Alliancebernstein
Jpmorgan Chase & Co
Jennifer Ranahan
TD Asset Management
Charles Schwab Investment Management
Dimensional Fund Advisors
Arrowpoint Asset Management
Goldman Sachs Group
T. Rowe Price Associates
Norges Bank Investment Management
Bank of New York Mellon
Bank of America Corporation
New York State Common Retirement Fund

View all funds holding Halozyme Therapeutics